Relmada Therapeutics, Inc. (RLMD)
NASDAQ: RLMD · Real-Time Price · USD
2.850
-0.130 (-4.36%)
Nov 20, 2024, 4:00 PM EST - Market closed
Relmada Therapeutics Employees
Relmada Therapeutics had 20 employees as of December 31, 2023. The number of employees increased by 6 or 42.86% compared to the previous year.
Employees
20
Change (1Y)
6
Growth (1Y)
42.86%
Revenue / Employee
n/a
Profits / Employee
-$4,324,369
Market Cap
86.00M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
So-Young International | 1,357 |
Harvard Bioscience | 416 |
EDAP TMS | 307 |
WORK Medical Technology Group LTD | 216 |
Quantum-Si incorporated | 159 |
Allakos | 131 |
Invivyd | 95 |
HilleVax | 90 |
RLMD News
- 6 days ago - Relmada Therapeutics Initiates Phase 1 Dosing with REL-P11 for Metabolic Disease - GlobeNewsWire
- 10 days ago - Relmada Therapeutics, Inc. (RLMD) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 13 days ago - Relmada Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update - PRNewsWire
- 16 days ago - Relmada Therapeutics to Report Third Quarter 2024 Financial Results on November 7, 2024 - GlobeNewsWire
- 2 months ago - Kuehn Law Encourages Investors of Relmada Therapeutics, Inc. to Contact Law Firm - PRNewsWire
- 3 months ago - Relmada Therapeutics, Inc. (RLMD) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Relmada Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update - PRNewsWire
- 3 months ago - Relmada Therapeutics to Report Second Quarter 2024 Financial Results on August 7, 2024 - GlobeNewsWire